SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium

Virus Research

Volumn 133, Issue 1, 2008, Pages 33-44

  Sims, Amy C ^a   Burkett, Susan E ^b   Yount, Boyd ^a   Pickles, Raymond J ^b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Coronavirus pathogenesis; Coronavirus replication; Human airway epithelia; SARS CoV; SARS CoV GFP

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANTISERUM; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CELL POLARITY; CELL STRAIN CACO 2; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CILIATED EPITHELIUM; CONTROLLED STUDY; CYTOPATHOLOGY; ENZYME LOCALIZATION; EPITHELIUM CELL; GENE DELETION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFECTION SENSITIVITY; INOCULATION; MICROVILLUS; MONOLAYER CULTURE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROGENY; RESPIRATORY EPITHELIUM; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SYRIAN HAMSTER; TIGHT JUNCTION; VERO CELL; VIRION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TYPING; WILD TYPE;

ANIMALS; CACO-2 CELLS; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CRICETINAE; EPITHELIAL CELLS; HUMANS; LUNG; MACACA MULATTA; MESOCRICETUS; MICE; PEPTIDYL-DIPEPTIDASE A; RESPIRATORY SYSTEM; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELLS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MESOCRICETUS AURATUS; SARS CORONAVIRUS;

EID: 40649099135     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.03.013     Document Type: Article

References (59)

1. Almazan F., Dediego M.L., Galan C., Escors D., Alvarez E., Ortego J., Sola I., Zuniga S., Alonso S., Moreno J.L., Nogales A., Capiscol C., and Enjuanes L. Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis. J. Virol. 80 21 (2006) 10900-10906
2. Baric R.S., and Sims A.C. Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs. Curr. Top. Microbiol. Immunol. 287 (2005) 229-252
3. Chen J., Zhang H.T., Xie Y.Q., Wan J.W., Lu Z.H., Wang D.T., Wang Q.Z., Xue X.H., Si W.X., Luo Y.F., and Qiu H.M. Morphological study of severe acute respiratory syndrome (SARS). Zhonghua Bing Li Xue Za Zhi 32 6 (2003) 516-520
4. Cheung O.Y., Chan J.W., Ng C.K., and Koo C.K. The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology 45 2 (2004) 119-124
5. Chinese S.M.E.C. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303 5664 (2004) 1666-1669
6. Chow K.C., Hsiao C.H., Lin T.Y., Chen C.L., and Chiou S.H. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am. J. Clin. Pathol. 121 4 (2004) 574-580
7. Chu C.M., Cheng V.C., Hung I.F., Wong M.M., Chan K.H., Chan K.S., Kao R.Y., Poon L.L., Wong C.L., Guan Y., Peiris J.S., and Yuen K.Y. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59 3 (2004) 252-256
8. Curtis K.M., Yount B., and Baric R.S. Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol. 76 3 (2002) 1422-1434
9. Fischer F., Stegen C.F., Koetzner C.A., and Masters P.S. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J. Virol. 71 7 (1997) 5148-5160
10. Franks T.J., Chong P.Y., Chui P., Galvin J.R., Lourens R.M., Reid A.H., Selbs E., McEvoy C.P., Hayden C.D., Fukuoka J., Taubenberger J.K., and Travis W.D. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34 8 (2003) 743-748
11. Fujita M. Flying foxes and economics. BATS 6 Spring (1988) 4-9
12. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., and Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302 5643 (2003) 276-278
13. Han Y., Geng H., Feng W., Tang X., Ou A., Lao Y., Xu Y., Lin H., Liu H., and Li Y. A follow-up study of 69 discharged SARS patients. J. Tradit. Chin. Med. 23 3 (2003) 214-217
14. Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., and Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U.S.A. 102 22 (2005) 7988-7993
15. Ibricevic A., Pekosz A., Walter M.J., Newby C., Battaile J.T., Brown E.G., Holtzman M.J., and Brody S.L. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80 15 (2006) 7469-7480
16. Jeffers S.A., Tusell S.M., Gillim-Ross L., Hemmila E.M., Achenbach J.E., Babcock G.J., Thomas Jr. W.D., Thackray L.B., Young M.D., Mason R.J., Ambrosino D.M., Wentworth D.E., Demartini J.C., and Holmes K.V. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U.S.A. 101 44 (2004) 15748-15753
17. Jia H.P., Look D.C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., and McCray Jr. P.B. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79 23 (2005) 14614-14621
18. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., and Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 20 (2003) 1953-1966
19. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D., Laman J.D., de Jong T., van Doornum G., Lim W., Ling A.E., Chan P.K., Tam J.S., Zambon M.C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.C., Stohr K., Peiris J.S., and Osterhaus A.D. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362 9380 (2003) 263-270
20. Lau, Y.L., Peiris, J.M., 2005. Pathogenesis of severe acute respiratory syndrome. Curr. Opin. Immunol.
21. Lau, S.K., Woo, P.C., Li, K.S., Huang, Y., Tsoi, H.W., Wong, B.H., Wong, S.S., Leung, S.Y., Chan, K.H., Yuen, K.Y., 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U.S.A.
22. Lawler J.V., Endy T.P., Hensley L.E., Garrison A., Fritz E.A., Lesar M., Baric R.S., Kulesh D.A., Norwood D.A., Wasieloski L.P., Ulrich M.P., Slezak T.R., Vitalis E., Huggins J.W., Jahrling P.B., and Paragas J. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med. 3 5 (2006) e149
23. Leung C.W., and Chiu W.K. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatr. Respir. Rev. 5 4 (2004) 275-288
24. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 6965 (2003) 450-454
25. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., and Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 310 5748 (2005) 676-679
26. Lu Y., Gong E.C., Zhang Q.Y., Gu J., Li X.W., Zhang B., Hou L., Shao H.Q., Gao Z.F., Zheng J., Fang W.G., and Zhong Y.F. Expression of SARS-CoV in various types of cells in lung tissues. Beijing Da Xue Xue Bao 37 5 (2005) 453-457
27. Martina B.E., Haagmans B.L., Kuiken T., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., Peiris J.S., Lim W., and Osterhaus A.D. Virology: SARS virus infection of cats and ferrets. Nature 425 6961 (2003) 915
28. Marzi A., Gramberg T., Simmons G., Moller P., Rennekamp A.J., Krumbiegel M., Geier M., Eisemann J., Turza N., Saunier B., Steinkasserer A., Becker S., Bates P., Hofmann H., and Pohlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78 21 (2004) 12090-12095
29. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., and Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 101 13 (2004) 4620-4624
30. Matsui H., Randell S.H., Peretti S.W., Davis C.W., and Boucher R.C. Coordinated clearance of periciliary liquid and mucus from airway surfaces. J. Clin. Invest. 102 6 (1998) 1125-1131
31. McAuliffe J., Vogel L., Roberts A., Fahle G., Fischer S., Shieh W.J., Butler E., Zaki S., St Claire M., Murphy B., and Subbarao K. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 330 1 (2004) 8-15
32. McCray, P.B., Jr., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H.P., Halabi, C., Sigmund, C.D., Meyerholz, D.K., Kirby, P., Look, D.C., Perlman, S., 2006. Lethal infection in K18-hACE2 mice infected with SARS-CoV. J. Virol.
33. Mellow T.E., Murphy P.C., Carson J.L., Noah T.L., Zhang L., and Pickles R.J. The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp. Lung Res. 30 1 (2004) 43-57
34. Nicholls J., and Peiris M. Good ACE, bad ACE do battle in lung injury, SARS. Nat. Med. 11 8 (2005) 821-822
35. Nicholls J., Dong X.P., Jiang G., and Peiris M. SARS: clinical virology and pathogenesis. Respirology 8 Suppl. (2003) S6-S8
36. Nicholls J.M., Poon L.L., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., Chu C.M., Hui P.K., Mak K.L., Lim W., Yan K.W., Chan K.H., Tsang N.C., Guan Y., Yuen K.Y., and Peiris J.S. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361 9371 (2003) 1773-1778
37. Osterhaus A.D., Fouchier R.A., and Kuiken T. The aetiology of SARS: Koch's postulates fulfilled. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 1447 (2004) 1081-1082
38. Pene F., Merlat A., Vabret A., Rozenberg F., Buzyn A., Dreyfus F., Cariou A., Freymuth F., and Lebon P. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin. Infect. Dis. 37 7 (2003) 929-932
39. Pickles R.J., McCarty D., Matsui H., Hart P.J., Randell S.H., and Boucher R.C. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J. Virol. 72 7 (1998) 6014-6023
40. Poon L.L., Chu D.K., Chan K.H., Wong O.K., Ellis T.M., Leung Y.H., Lau S.K., Woo P.C., Suen K.Y., Yuen K.Y., Guan Y., and Peiris J.S. Identification of a novel coronavirus in bats. J. Virol. 79 4 (2005) 2001-2009
41. Roberts A., Paddock C., Vogel L., Butler E., Zaki S., and Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol. 79 9 (2005) 5833-5838
42. Roberts A., Vogel L., Guarner J., Hayes N., Murphy B., Zaki S., and Subbarao K. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol. 79 1 (2005) 503-511
43. Sola I., Alonso S., Zuniga S., Balasch M., Plana-Duran J., and Enjuanes L. Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J. Virol. 77 7 (2003) 4357-4369
44. Stonebraker J.R., Wagner D., Lefensty R.W., Burns K., Gendler S.J., Bergelson J.M., Boucher R.C., O'Neal W.K., and Pickles R.J. Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection. J. Virol. 78 24 (2004) 13755-13768
45. Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., Packard M., Shieh W.J., Zaki S., and Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78 7 (2004) 3572-3577
46. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., and Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. U.S.A. 101 8 (2004) 2536-2541
47. Thompson C.I., Barclay W.S., Zambon M.C., and Pickles R.J. Infection of human airway epithelium by human and avian strains of influenza a virus. J. Virol. 80 16 (2006) 8060-8068
48. To K.F., Tong J.H., Chan P.K., Au F.W., Chim S.S., Chan K.C., Cheung J.L., Liu E.Y., Tse G.M., Lo A.W., Lo Y.M., and Ng H.K. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J. Pathol. 202 2 (2004) 157-163
49. Tseng C.T., Tseng J., Perrone L., Worthy M., Popov V., and Peters C.J. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 79 15 (2005) 9470-9479
50. Tseng, C.T., Huang, C., Newman, P., Wang, N., Narayanan, K., Watts, D.M., Makino, S., Packard, M., Zaki, S.R., Chan, T.S., Peters, C.J., 2006. SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor. J. Virol.
51. Wang G., Deering C., Macke M., Shao J., Burns R., Blau D.M., Holmes K.V., Davidson B.L., Perlman S., and McCray Jr. P.B. Human coronavirus 229E infects polarized airway epithelia from the apical surface. J. Virol. 74 19 (2000) 9234-9239
52. Weingartl H., Czub M., Czub S., Neufeld J., Marszal P., Gren J., Smith G., Jones S., Proulx R., Deschambault Y., Grudeski E., Andonov A., He R., Li Y., Copps J., Grolla A., Dick D., Berry J., Ganske S., Manning L., and Cao J. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J. Virol. 78 22 (2004) 12672-12676
53. Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., and Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78 11 (2004) 5642-5650
54. Yount B., Denison M.R., Weiss S.R., and Baric R.S. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 76 21 (2002) 11065-11078
55. Yount B., Curtis K.M., Fritz E.A., Hensley L.E., Jahrling P.B., Prentice E., Denison M.R., Geisbert T.W., and Baric R.S. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U.S.A. 100 22 (2003) 12995-13000
56. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., and Pickles R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76 11 (2002) 5654-5666
57. Zhang Q.L., Ding Y.Q., He L., Wang W., Zhang J.H., Wang H.J., Cai J.J., Geng J., Lu Y.D., and Luo Y.L. Detection of cell apoptosis in the pathological tissues of patients with SARS and its significance. Di Yi Jun Yi Da Xue Xue Bao 23 8 (2003) 770-773
58. Zhang Q.L., Ding Y.Q., Hou J.L., He L., Huang Z.X., Wang H.J., Cai J.J., Zhang J.H., Zhang W.L., Geng J., Li X., Kang W., Yang L., Shen H., Li Z.G., Han H.X., and Lu Y.D. Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization. Di Yi Jun Yi Da Xue Xue Bao 23 11 (2003) 1125-1127
59. Zhang L., Bukreyev A., Thompson C.I., Watson B., Peeples M.E., Collins P.L., and Pickles R.J. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79 2 (2005) 1113-1124